(NANC) Unusual Whales Subversive - Overview
Etf: Large-Cap, Tech, Healthcare, Financial
Dividends
| Dividend Yield | 0.21% |
| Yield on Cost 5y | 0.38% |
| Yield CAGR 5y | -42.06% |
| Payout Consistency | 81.5% |
| Payout Ratio | - |
| Risk 5d forecast | |
|---|---|
| Volatility | 19.2% |
| Relative Tail Risk | 4.61% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.45 |
| Alpha | -3.41 |
| Character TTM | |
|---|---|
| Beta | 0.989 |
| Beta Downside | 0.981 |
| Drawdowns 3y | |
|---|---|
| Max DD | 20.94% |
| CAGR/Max DD | 1.10 |
Description: NANC Unusual Whales Subversive January 02, 2026
The Unusual Whales Subversive Democratic Trading ETF (BATS:NANC) is an actively managed U.S. ETF that invests primarily in the equity securities of publicly-traded companies in which sitting Democratic members of Congress-or their immediate family members-have disclosed holdings under the STOCK Act. Its stated objective is to capture potential market signals from these politically disclosed positions while delivering a large-blend exposure.
Key metrics (as of the latest filing) include an expense ratio of roughly 0.85%, assets under management near $120 million, and an average portfolio turnover of 45% annually, reflecting the fund’s active rebalancing around new congressional disclosures. Because the holdings are concentrated in sectors that attract legislative attention-such as energy, healthcare, and technology-the ETF’s performance is sensitive to policy shifts (e.g., renewable-energy incentives, drug-price reforms) and broader macro drivers like U.S. GDP growth and interest-rate expectations.
For a deeper quantitative breakdown, you might explore ValueRay’s analytics platform.
What is the price of NANC shares?
Over the past week, the price has changed by -1.46%, over one month by -2.74%, over three months by -0.43% and over the past year by +11.61%.
Is NANC a buy, sell or hold?
What are the forecasts/targets for the NANC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 51 | 12.9% |
NANC Fundamental Data Overview February 04, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 264.8m USD (264.8m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 264.8m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 264.8m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 9.56% (E(264.8m)/V(264.8m) * Re(9.56%) + (debt-free company))
Discount Rate = 9.56% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)